Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE recommends 4p breast cancer drug for healthy women

November 29, 2016
Research and Development, Sales and Marketing NICE, anastrozole, breast cancer

NICE has published new draft guidance calling for women with a strong family history of breast cancer to be offered …

News
ireena_vittal

Ireena Vittal joins Cipla executive board

November 29, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cipla, appointment

Indian drug maker Cipla has expanded its board with the addition of Ireena Vittal as an independent director, effective 1 …

Appointment

PrimeVigilance and PharmInvent combine to create leading, international full service pharmacovigilance, medical information and regulatory service provider

November 29, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

PrimeVigilance and PharmInvent are pleased to announce that they are now working together as an integrated service provider following the …

News
Press release
cmglee_cambridge_cancer_research_web

UK oral cancer rates soar 68% over two decades

November 29, 2016
Manufacturing and Production, Medical Communications, Research and Development Cancer Research UK, Oral cancer, mouth cancer

As a move to raise awareness during Mouth Cancer Action Month, Cancer Research UK (CRUK) has released figures of an …

News
shutterstock_232245868

Personalised medicine to drive global lung cancer market to 2020

November 29, 2016
Manufacturing and Production, Sales and Marketing Technavio, lung cancer, non-small cell lung cancer

According to a new report from Technavio, the global lung cancer therapeutics market is projected to grow at more than …

News
wockhardt_hospital_mumbai

Wockhardt UK sterile site hit with FDA warning

November 29, 2016
Manufacturing and Production FDA, Wockhardt, Wrexham

Mumbai-based pharmaceutical and biotechnology firm Wockhardt has been hit with more manufacturing woes as the FDA issued a warning letter …

News

FDA orphan drug designation doubles PhaseRx shares

November 28, 2016
Manufacturing and Production, Research and Development, Sales and Marketing FDA, Orphan Drug Designation, PhaseRx

PhaseRx is celebrating as its lead drug candidate PRX-OTC has been orphan drug designation by the US FDA for the …

News
shutterstock_57369385

Biosimilars and Generics: A no-brainer for treatment?

November 28, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biosimilars, generics

The industry is poised on the potential widespread adoption of many revolutionary technologies; foremost among them are biosimilars and generics, …

Feature
roche_florence_sc_site

Patheon acquires state-of-the-art manufacturing facility from Roche

November 28, 2016
Manufacturing and Production Patheon, Roche, South Carolina

Patheon, a provider of drug development and delivery to the pharmaceutical and biopharma sectors, announced that it has acquired a …

News
syqe-marijuana_inhaler

Teva to market world’s first medical marijuana inhaler

November 28, 2016
Research and Development, Sales and Marketing

Israel’s Teva Pharmaceutical Industries has signed an agreement with Tel Aviv-based biotech Syqe Medical for the distribution and marketing of …

News
kymab

Chinese investors push Kymab backing to $100 million

November 28, 2016
Sales and Marketing Bill & Melina Gates Foundation, China, kymab

Kymab, the UK-based antibody biopharmaceutical group, announced that it has secured $100 million in funding. The company raised the funds …

News
pfizer_building2web

Pfizer scraps €400m Dublin facility expansion

November 28, 2016
Manufacturing and Production, Sales and Marketing Pfizer, bococizumab

Pfizer has U-turned on its intention to bolster operations at its Grange Castle, Dublin facility in a 34,500 square-metre expansion …

News
takeda_tokyo_hq

Takeda gains marketing authorisation for multiple myeloma pill

November 28, 2016
Sales and Marketing Takeda, multiple myeloma

Takeda Pharmaceutical has announced that they have received conditional marketing authorisation for Ninlaro (ixazomib) for treatment of adult patients with …

News
european_commission_web

GSK applies for EU approval for shingles vaccine

November 28, 2016
Sales and Marketing European Commission, GSK, GlaxoSmithKline, Shingrix, shingles

After filing for FDA approval in October, GlaxoSmithKline has now applied for approval from the European Commission (EC) for its …

News
uday_baldota

Taro announces appointment of new CEO

November 25, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Taro pharmaceutical, sun pharmaceutical

Taro Pharmaceutical announced that Uday Baldota will take up the position of CEO and will begin the role in early …

Appointment

J&J reportedly poised to acquire Europe’s biggest biotech

November 25, 2016
Sales and Marketing Actelion, J&J, JJ, Johnson and Johnson, acquisition

Johnson & Johnson could be eyeing a takeover of Swiss biotech Actelion, Europe’s biggest biotech, according to insiders, Bloomberg has …

News

GSK reaches endgame of race to develop anaemia drug

November 25, 2016
Research and Development, Sales and Marketing AstraZeneca, Daprodustat, GSK, GlaxoSmithKline, anaemia

GlaxoSmithKline has announced that they will begin Phase 3 development of their anaemia drug, daprodustat. The drug is an oral …

News
top_ten_1

Top Ten most popular articles on Pharmafile this week

November 25, 2016
Medical Communications November, news, pharmaceutical, top 10, top ten, top ten stories

This week has seen the pharmaceutical industry return to business as usual after the presidential election provided a boost to …

News
deb_lancaster

Insider interview: Roche discusses efficacy of CDF and NICE

November 25, 2016
Medical Communications, Sales and Marketing CDF, NICE, Roche

Deborah Lancaster, Head of Market Access at Roche, discusses, in the latest issue of Pharmafile, the efficacy of the National …

News
nice_aerial

Lowered price wins NICE approval for Janssen leukaemia treatment

November 25, 2016
Medical Communications, Sales and Marketing Janssen, NICE, SMC, chronic lymphocytic leukaemia, ibrutinib, imbruvica

After being knocked back in the beginning of June this year, NICE has announced that Janssen’s Imbruvica (ibrutinib) will now …

News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026